S532 The Utility of Cologuard for CRC Screening After a Normal Colonoscopy

Abhinav Rao,Shivam Kalra,Brett D. Van Leer-Greenberg,Don Rockey
DOI: https://doi.org/10.14309/01.ajg.0001031496.89490.2d
2024-10-26
The American Journal of Gastroenterology
Abstract:Multitarget stool DNA tests (i.e., Cologuard ® ) are currently used in average-risk patients as a primary method of screening for colorectal cancer (CRC). However, Cologuard ® is also being used in patients who previously underwent colonoscopy who wish to avoid repeat colonoscopy. Here, in a large primary care practice setting, our aim was to evaluate the diagnostic performance of Cologuard ® in patients who had a previously normal colonoscopy.
gastroenterology & hepatology
What problem does this paper attempt to address?